The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection
Journal of Viral Hepatitis · 2023-03 · 30 (3) · 195-200
DOI: 10.1111/jvh.13779 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Viral Hepatitis, online erschienen am 12.12.2022. Verfasst von Rohit Nathani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Icahn School of Medicine at Mount Sinai Morningside, and West Hospital, New York, New York, USA. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis D. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Hepatitis D virus (HDV) infection is highly prevalent in patients with chronic hepatitis B (CHB). AASLD guidelines recommend a risk‐based screening approach. Our aim was to ascertain if the risk‐based approach leads to appropriate HDV screening, identify targets to improve screening rates, and study HDV clinical burden. CHB patients screened for HDV from 01/2016 to 12/2021 were identified. Level of training and specialty of providers ordering HDV screening tests were determined. HDV seropositive (HDV+) patient charts were reviewed for the presence of individual risk factors per the AASLD guidelines to determine if they met screening criteria. The severity of liver disease at the time of HDV screening was compared between the HDV+ group and a matched (based on age, hepatitis B e antigen status, BMI and sex) HDV seronegative (HDV−) group. During the study period, 1444/11,190 CHB patients were screened for HDV. Most screening tests were ordered by gastroenterology (90.2%) specialists and attending physicians (80.5%). HDV+ rate was 88/1444 (6%), and 72 HDV+ patients had complete information for analysis. 18% of HDV+ patients would be missed by a risk‐based screening approach due to unreported or negative risk factors (see Table). A significantly higher number of HDV+ patients had developed significant fibrosis ( p = 0.001) and cirrhosis ( p < 0.01) by the time of screening than HDV− ( n = 67) patients. In conclusion, targeted interventions are needed towards trainees and primary care clinics to improve screening rates. Current risk‐based criteria do not appropriately screen for HDV. It is time for universal screening of HDV in CHB patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Icahn School of Medicine at Mount Sinai Morningside, and West Hospital, New York, New York, USA.
- Department of Medicine, Icahn School of Medicine at Mount Sinai Beth Israel Hospital, New York, New York, USA.
- Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai Beth Israel, Morningside, and West Hospital, New York, New York, USA.
- Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Division of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai Beth Israel, New York, New York, USA.
Zitieren
APA
Nathani, R., Leibowitz, R., Giri, D., Villarroel, C., Salman, S., Sehmbhi, M., Yoon, B. H., Dinani, A., & Weisberg, I. (2023). The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection. Journal of Viral Hepatitis, 30(3), 195-200. https://doi.org/10.1111/jvh.13779
Vancouver
Nathani R, Leibowitz R, Giri D, Villarroel C, Salman S, Sehmbhi M, et al. The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection. Journal of Viral Hepatitis. 2023;30(3):195-200. doi:10.1111/jvh.13779
BibTeX
@article{Nathani2023,
author = {Nathani, Rohit and Leibowitz, Randy and Giri, Dewan and Villarroel, Carolina and Salman, Sidra and Sehmbhi, Mantej and Yoon, Bo Hyung and Dinani, Amreen and Weisberg, Ilan},
title = {The Delta Delta: Gaps in screening and patient assessment for hepatitis D virus infection},
journal = {Journal of Viral Hepatitis},
year = {2023},
volume = {30},
number = {3},
pages = {195--200},
doi = {10.1111/jvh.13779}
}
EUVIMED